Government Briefs

Perhaps the kindest thing to say about the recent report from the National Academy of Sciences on the controversial topic of laboratory animals is that it’s finished. The 73-page report, which cost $315,000 and took three years to write, breaks little new ground, coming out in support of the continued use of animals in research and urging Congress not to pass any more laws regulating their use until the current rules have been digested. The report’s most striking features are its ra

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Perhaps the kindest thing to say about the recent report from the National Academy of Sciences on the controversial topic of laboratory animals is that it’s finished. The 73-page report, which cost $315,000 and took three years to write, breaks little new ground, coming out in support of the continued use of animals in research and urging Congress not to pass any more laws regulating their use until the current rules have been digested. The report’s most striking features are its rare dissenting statements— one by physiologist Arthur Guyton, arguing that the animal rights movement must be stopped, and the other by activist Christine Stevens, saying the report should do more to protect animals and discourage their use in research. Panel chairman Norman Hackerman explains why the academy permitted dissenting addenda in a preface. Consensus, he says, may never be possible on some issues.

This report won’t be the academy’s ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies